ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-reflux Infant Formula Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-25D17414
Home | Market Reports | Food & Drink| Food
Global Anti reflux Infant Formula Market Research Report 2024
BUY CHAPTERS

Global Anti-reflux Infant Formula Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-25D17414
Report
October 2025
Pages:146
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aptamil
Bobbie
DANA Dairy
HiPP
Perrigo
Mead Johnson HCP
SMA Baby Club

Anti-reflux Infant Formula Market

The global Anti-reflux Infant Formula market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Online Sales accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Anti-reflux Infant Formula leading manufacturers including Aptamil, Bobbie, DANA Dairy, HiPP, Kendal Nutricare, Mead Johnson HCP, Perrigo, SMA Baby Club, etc., dominate supply; the top five capture approximately % of global revenue, with Aptamil leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Anti-reflux Infant Formula market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Anti-reflux Infant Formula Market Report

Report Metric Details
Report Name Anti-reflux Infant Formula Market
Segment by Type
  • 0-6 Months Infant Formula
  • 6-12 Months Infant Formula
  • 1 Year and Above Infant Formula
Segment by Application
  • Online Sales
  • Offline Sales
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aptamil, Bobbie, DANA Dairy, HiPP, Kendal Nutricare, Mead Johnson HCP, Perrigo, SMA Baby Club
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Anti-reflux Infant Formula study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Anti-reflux Infant Formula Market report?

Ans: The main players in the Anti-reflux Infant Formula Market are Aptamil, Bobbie, DANA Dairy, HiPP, Kendal Nutricare, Mead Johnson HCP, Perrigo, SMA Baby Club

What are the Application segmentation covered in the Anti-reflux Infant Formula Market report?

Ans: The Applications covered in the Anti-reflux Infant Formula Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Anti-reflux Infant Formula Market report?

Ans: The Types covered in the Anti-reflux Infant Formula Market report are 0-6 Months Infant Formula, 6-12 Months Infant Formula, 1 Year and Above Infant Formula

1 Study Coverage
1.1 Introduction to Anti-reflux Infant Formula: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Anti-reflux Infant Formula Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 0-6 Months Infant Formula
1.2.3 6-12 Months Infant Formula
1.2.4 1 Year and Above Infant Formula
1.3 Market Segmentation by Application
1.3.1 Global Anti-reflux Infant Formula Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-reflux Infant Formula Revenue Estimates and Forecasts 2020-2031
2.2 Global Anti-reflux Infant Formula Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Anti-reflux Infant Formula Sales Estimates and Forecasts 2020-2031
2.4 Global Anti-reflux Infant Formula Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Anti-reflux Infant Formula Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Anti-reflux Infant Formula Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 0-6 Months Infant Formula Market Size by Manufacturers
3.5.2 6-12 Months Infant Formula Market Size by Manufacturers
3.5.3 1 Year and Above Infant Formula Market Size by Manufacturers
3.6 Global Anti-reflux Infant Formula Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Anti-reflux Infant Formula Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Anti-reflux Infant Formula Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Anti-reflux Infant Formula Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Anti-reflux Infant Formula Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Anti-reflux Infant Formula Sales and Revenue by Type (2020-2031)
6.4 North America Anti-reflux Infant Formula Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Anti-reflux Infant Formula Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Anti-reflux Infant Formula Sales and Revenue by Type (2020-2031)
7.4 Europe Anti-reflux Infant Formula Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Anti-reflux Infant Formula Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Anti-reflux Infant Formula Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Anti-reflux Infant Formula Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Anti-reflux Infant Formula Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Anti-reflux Infant Formula Sales and Revenue by Type (2020-2031)
9.4 Central and South America Anti-reflux Infant Formula Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Anti-reflux Infant Formula Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Anti-reflux Infant Formula Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Anti-reflux Infant Formula Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Anti-reflux Infant Formula Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Aptamil
11.1.1 Aptamil Corporation Information
11.1.2 Aptamil Business Overview
11.1.3 Aptamil Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.1.4 Aptamil Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Aptamil Anti-reflux Infant Formula Sales by Product in 2024
11.1.6 Aptamil Anti-reflux Infant Formula Sales by Application in 2024
11.1.7 Aptamil Anti-reflux Infant Formula Sales by Geographic Area in 2024
11.1.8 Aptamil Anti-reflux Infant Formula SWOT Analysis
11.1.9 Aptamil Recent Developments
11.2 Bobbie
11.2.1 Bobbie Corporation Information
11.2.2 Bobbie Business Overview
11.2.3 Bobbie Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.2.4 Bobbie Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bobbie Anti-reflux Infant Formula Sales by Product in 2024
11.2.6 Bobbie Anti-reflux Infant Formula Sales by Application in 2024
11.2.7 Bobbie Anti-reflux Infant Formula Sales by Geographic Area in 2024
11.2.8 Bobbie Anti-reflux Infant Formula SWOT Analysis
11.2.9 Bobbie Recent Developments
11.3 DANA Dairy
11.3.1 DANA Dairy Corporation Information
11.3.2 DANA Dairy Business Overview
11.3.3 DANA Dairy Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.3.4 DANA Dairy Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 DANA Dairy Anti-reflux Infant Formula Sales by Product in 2024
11.3.6 DANA Dairy Anti-reflux Infant Formula Sales by Application in 2024
11.3.7 DANA Dairy Anti-reflux Infant Formula Sales by Geographic Area in 2024
11.3.8 DANA Dairy Anti-reflux Infant Formula SWOT Analysis
11.3.9 DANA Dairy Recent Developments
11.4 HiPP
11.4.1 HiPP Corporation Information
11.4.2 HiPP Business Overview
11.4.3 HiPP Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.4.4 HiPP Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 HiPP Anti-reflux Infant Formula Sales by Product in 2024
11.4.6 HiPP Anti-reflux Infant Formula Sales by Application in 2024
11.4.7 HiPP Anti-reflux Infant Formula Sales by Geographic Area in 2024
11.4.8 HiPP Anti-reflux Infant Formula SWOT Analysis
11.4.9 HiPP Recent Developments
11.5 Kendal Nutricare
11.5.1 Kendal Nutricare Corporation Information
11.5.2 Kendal Nutricare Business Overview
11.5.3 Kendal Nutricare Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.5.4 Kendal Nutricare Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Kendal Nutricare Anti-reflux Infant Formula Sales by Product in 2024
11.5.6 Kendal Nutricare Anti-reflux Infant Formula Sales by Application in 2024
11.5.7 Kendal Nutricare Anti-reflux Infant Formula Sales by Geographic Area in 2024
11.5.8 Kendal Nutricare Anti-reflux Infant Formula SWOT Analysis
11.5.9 Kendal Nutricare Recent Developments
11.6 Mead Johnson HCP
11.6.1 Mead Johnson HCP Corporation Information
11.6.2 Mead Johnson HCP Business Overview
11.6.3 Mead Johnson HCP Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.6.4 Mead Johnson HCP Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Mead Johnson HCP Recent Developments
11.7 Perrigo
11.7.1 Perrigo Corporation Information
11.7.2 Perrigo Business Overview
11.7.3 Perrigo Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.7.4 Perrigo Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Perrigo Recent Developments
11.8 SMA Baby Club
11.8.1 SMA Baby Club Corporation Information
11.8.2 SMA Baby Club Business Overview
11.8.3 SMA Baby Club Anti-reflux Infant Formula Product Models, Descriptions and Specifications
11.8.4 SMA Baby Club Anti-reflux Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SMA Baby Club Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Anti-reflux Infant Formula Industry Chain
12.2 Anti-reflux Infant Formula Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Anti-reflux Infant Formula Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Anti-reflux Infant Formula Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Anti-reflux Infant Formula Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Anti-reflux Infant Formula Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Aptamil
Bobbie
DANA Dairy
HiPP
Perrigo
Mead Johnson HCP
SMA Baby Club
List of Tables
 Table 1. Global Anti-reflux Infant Formula Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Anti-reflux Infant Formula Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Anti-reflux Infant Formula Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Anti-reflux Infant Formula Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Anti-reflux Infant Formula Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Anti-reflux Infant Formula Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Anti-reflux Infant Formula Sales by Region (2020-2025) & (K Units)
 Table 8. Global Anti-reflux Infant Formula Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Anti-reflux Infant Formula Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Anti-reflux Infant Formula Sales Share by Manufacturers (2020-2025)
 Table 12. Global Anti-reflux Infant Formula Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Anti-reflux Infant Formula Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Anti-reflux Infant Formula by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-reflux Infant Formula as of 2024)
 Table 16. Global Anti-reflux Infant Formula Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Anti-reflux Infant Formula Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Anti-reflux Infant Formula Manufacturing Base and Headquarters
 Table 19. Global Anti-reflux Infant Formula Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Anti-reflux Infant Formula Sales by Type (2020-2025) & (K Units)
 Table 23. Global Anti-reflux Infant Formula Sales by Type (2026-2031) & (K Units)
 Table 24. Global Anti-reflux Infant Formula Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Anti-reflux Infant Formula Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Anti-reflux Infant Formula ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Anti-reflux Infant Formula Sales by Application (2020-2025) & (K Units)
 Table 29. Global Anti-reflux Infant Formula Sales by Application (2026-2031) & (K Units)
 Table 30. Anti-reflux Infant Formula High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Anti-reflux Infant Formula Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Anti-reflux Infant Formula Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Anti-reflux Infant Formula ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Anti-reflux Infant Formula Growth Accelerators and Market Barriers
 Table 37. North America Anti-reflux Infant Formula Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Anti-reflux Infant Formula Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Anti-reflux Infant Formula Growth Accelerators and Market Barriers
 Table 40. Europe Anti-reflux Infant Formula Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Anti-reflux Infant Formula Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Anti-reflux Infant Formula Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Anti-reflux Infant Formula Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Anti-reflux Infant Formula Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Anti-reflux Infant Formula Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Anti-reflux Infant Formula Investment Opportunities and Key Challenges
 Table 47. Central and South America Anti-reflux Infant Formula Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Anti-reflux Infant Formula Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Anti-reflux Infant Formula Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Aptamil Corporation Information
 Table 51. Aptamil Description and Major Businesses
 Table 52. Aptamil Product Models, Descriptions and Specifications
 Table 53. Aptamil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Aptamil Sales Value Proportion by Product in 2024
 Table 55. Aptamil Sales Value Proportion by Application in 2024
 Table 56. Aptamil Sales Value Proportion by Geographic Area in 2024
 Table 57. Aptamil Anti-reflux Infant Formula SWOT Analysis
 Table 58. Aptamil Recent Developments
 Table 59. Bobbie Corporation Information
 Table 60. Bobbie Description and Major Businesses
 Table 61. Bobbie Product Models, Descriptions and Specifications
 Table 62. Bobbie Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Bobbie Sales Value Proportion by Product in 2024
 Table 64. Bobbie Sales Value Proportion by Application in 2024
 Table 65. Bobbie Sales Value Proportion by Geographic Area in 2024
 Table 66. Bobbie Anti-reflux Infant Formula SWOT Analysis
 Table 67. Bobbie Recent Developments
 Table 68. DANA Dairy Corporation Information
 Table 69. DANA Dairy Description and Major Businesses
 Table 70. DANA Dairy Product Models, Descriptions and Specifications
 Table 71. DANA Dairy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. DANA Dairy Sales Value Proportion by Product in 2024
 Table 73. DANA Dairy Sales Value Proportion by Application in 2024
 Table 74. DANA Dairy Sales Value Proportion by Geographic Area in 2024
 Table 75. DANA Dairy Anti-reflux Infant Formula SWOT Analysis
 Table 76. DANA Dairy Recent Developments
 Table 77. HiPP Corporation Information
 Table 78. HiPP Description and Major Businesses
 Table 79. HiPP Product Models, Descriptions and Specifications
 Table 80. HiPP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. HiPP Sales Value Proportion by Product in 2024
 Table 82. HiPP Sales Value Proportion by Application in 2024
 Table 83. HiPP Sales Value Proportion by Geographic Area in 2024
 Table 84. HiPP Anti-reflux Infant Formula SWOT Analysis
 Table 85. HiPP Recent Developments
 Table 86. Kendal Nutricare Corporation Information
 Table 87. Kendal Nutricare Description and Major Businesses
 Table 88. Kendal Nutricare Product Models, Descriptions and Specifications
 Table 89. Kendal Nutricare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Kendal Nutricare Sales Value Proportion by Product in 2024
 Table 91. Kendal Nutricare Sales Value Proportion by Application in 2024
 Table 92. Kendal Nutricare Sales Value Proportion by Geographic Area in 2024
 Table 93. Kendal Nutricare Anti-reflux Infant Formula SWOT Analysis
 Table 94. Kendal Nutricare Recent Developments
 Table 95. Mead Johnson HCP Corporation Information
 Table 96. Mead Johnson HCP Description and Major Businesses
 Table 97. Mead Johnson HCP Product Models, Descriptions and Specifications
 Table 98. Mead Johnson HCP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Mead Johnson HCP Recent Developments
 Table 100. Perrigo Corporation Information
 Table 101. Perrigo Description and Major Businesses
 Table 102. Perrigo Product Models, Descriptions and Specifications
 Table 103. Perrigo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Perrigo Recent Developments
 Table 105. SMA Baby Club Corporation Information
 Table 106. SMA Baby Club Description and Major Businesses
 Table 107. SMA Baby Club Product Models, Descriptions and Specifications
 Table 108. SMA Baby Club Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. SMA Baby Club Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Anti-reflux Infant Formula Product Picture
 Figure 2. Global Anti-reflux Infant Formula Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 0-6 Months Infant Formula Product Picture
 Figure 4. 6-12 Months Infant Formula Product Picture
 Figure 5. 1 Year and Above Infant Formula Product Picture
 Figure 6. Global Anti-reflux Infant Formula Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Online Sales
 Figure 8. Offline Sales
 Figure 9. Anti-reflux Infant Formula Report Years Considered
 Figure 10. Global Anti-reflux Infant Formula Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Anti-reflux Infant Formula Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Anti-reflux Infant Formula Revenue Market Share by Region (2020-2031)
 Figure 14. Global Anti-reflux Infant Formula Sales (2020-2031) & (K Units)
 Figure 15. Global Anti-reflux Infant Formula Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Anti-reflux Infant Formula Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Anti-reflux Infant Formula Sales Volume Market Share in 2024
 Figure 18. Global Anti-reflux Infant Formula Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. 0-6 Months Infant Formula Revenue Market Share by Manufacturer in 2024
 Figure 21. 6-12 Months Infant Formula Revenue Market Share by Manufacturer in 2024
 Figure 22. 1 Year and Above Infant Formula Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Anti-reflux Infant Formula Sales Market Share by Type (2020-2031)
 Figure 24. Global Anti-reflux Infant Formula Revenue Market Share by Type (2020-2031)
 Figure 25. Global Anti-reflux Infant Formula Sales Market Share by Application (2020-2031)
 Figure 26. Global Anti-reflux Infant Formula Revenue Market Share by Application (2020-2031)
 Figure 27. North America Anti-reflux Infant Formula Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Anti-reflux Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Anti-reflux Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 30. North America Anti-reflux Infant Formula Sales Volume (K Units) by Type (2020- 2031)
 Figure 31. North America Anti-reflux Infant Formula Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Anti-reflux Infant Formula Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America Anti-reflux Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Anti-reflux Infant Formula Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Anti-reflux Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Anti-reflux Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Anti-reflux Infant Formula Sales Volume (K Units) by Type (2020-2031)
 Figure 41. Europe Anti-reflux Infant Formula Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Anti-reflux Infant Formula Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe Anti-reflux Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 45. France Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Anti-reflux Infant Formula Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Anti-reflux Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Anti-reflux Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Anti-reflux Infant Formula Sales Volume (K Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Anti-reflux Infant Formula Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Anti-reflux Infant Formula Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Anti-reflux Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 60. India Anti-reflux Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Anti-reflux Infant Formula Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Anti-reflux Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Anti-reflux Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Anti-reflux Infant Formula Sales Volume (K Units) by Type (2021-2031)
 Figure 65. Central and South America Anti-reflux Infant Formula Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Anti-reflux Infant Formula Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America Anti-reflux Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Anti-reflux Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Anti-reflux Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Anti-reflux Infant Formula Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Anti-reflux Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Anti-reflux Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Anti-reflux Infant Formula Sales Volume (K Units) by Type (2021-2031)
 Figure 74. South America Anti-reflux Infant Formula Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Anti-reflux Infant Formula Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Anti-reflux Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Anti-reflux Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Anti-reflux Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Anti-reflux Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Anti-reflux Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 81. Anti-reflux Infant Formula Industry Chain Mapping
 Figure 82. Regional Anti-reflux Infant Formula Manufacturing Base Distribution (%)
 Figure 83. Global Anti-reflux Infant Formula Production Market Share by Region (2020-2031)
 Figure 84. Anti-reflux Infant Formula Production Process
 Figure 85. Regional Anti-reflux Infant Formula Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Liquid Infant Formula Market Research Report 2025
Global Dairy Free Infant Formulas Market Research Report 2024
Global Amino Acid Based Infant Formula Market Research Report 2024
Commercial Infant Formulas Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global A2 Milk Infant Formula Market Research Report 2024
Global Lactose Free Baby Formula Market Research Report 2025
Global Hypoallergenic Infant Formula Market Research Report 2024
Global Anti Reflux Device Market Research Report 2024
Global Iron Fortified Infant Formula Market Research Report 2024
Global Infant Formula Milk Powder With A2 beta casein Market Research Report 2024
Global Infant Formulas with A2 Beta Casein Market Research Report 2025
Baby Foods and Formula Market
Global Non Dairy Baby Formula Market Research Report 2024
Global Baby Formula Nutritions Products Market Research Report 2024
Global Infant Feeding Tube Market Research Report 2024
Global Instant Formula Milk Powder Market Research Report 2024
Global Infant Nutritional Premix Market Research Report 2024
Global Reflux Extractors Market Research Report 2025
Global Anti Spit up Formula Market Insights Forecast to 2030
Global Baby Formula Dispenser Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions